Atossa Therapeutics, Inc. Common Stock

ATOS XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

42M

Short interest (May 15)

4.0%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.73%

↑ 14.1%

Available Shares

70K

↓ 7.0%

Price Chart

Company Overview

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001488039

Asset Type: CS

Market Data

Market Cap: $41,765,100

Employees: 14

Status: Active

Short Interest

Current Borrow Fee 0.73%

Range: 0.58% - 0.73%

Available Shares 70K

Range: 65K - 150K

Recent Changes

Fee Change: ↑ 21.8%

Available Change: ↓ 10.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime